Mission, Vision, and Values

Our Mission

To contribute to the enrichment of quality of life around the world through the creation of innovative pharmaceuticals, and through the provision of pharmaceuticals addressing diverse medical needs.

2025 Vision

Global Pharma Innovator with Competitive Advantage in Oncology

  • To have Specialty area* business centered on Oncology business as the core business
  • To have enriched regional value products** aligned with regional market
  • To have innovative products and pipeline changing SOC***
  • To realize shareholders’ value through highly efficient management
  • *Specialty area: Drugs mainly prescribed at Hospital and/or by Specialty practitioners
  • **regional value products: Products aligned with regional market
  • ***SOC: Standard of Care

Core Values and Commitments

In alignment with our mission, we have identified "Core Values and Commitments" as the basis for an attitude of cooperation and proper value judgments and as the criteria for our business activities and decision making. In addition, we have established the DAIICHI SANKYO Group Corporate Conduct Charter* to act with the highest ethical standards and a good social conscience appropriate for a company engaged in a business that affects human lives.

Core Values comprise the following: Innovation, Integrity, and Accountability.

Based on our "Core Values", we have formulated our "Commitments". Each member of DAIICHI SANKYO should look back to the Core Values and Commitments before embarking on a course of action.

Core Values

  • Innovation
  • Integrity
  • Accountability


Innovation ────the introduction of new ideas, methods, or invention
Integrity ──────the quality of being honest and of always having high moral principles
Accountability ────being responsible for the effects of your actions, and being willing to explain or be criticized for them


  • 1. To create innovative medicines changing SOC*1
  • *1  SOC (Standard of Care) : Universally applied best treatment practice in today’s medical science
  • 2. To take a global perspective, and respect regional values
  • 3. To foster intellectual curiosity and strategic insight
  • 4. To provide the highest quality medical information
  • 5. To provide a stable supply of top-quality pharmaceutical products
  • 6. To be an ethical, trusted, and respectful partner
  • 7. To be accountable for achieving our goals
  • 8. To demonstrate professionalism, respect for others and teamwork

Corporate Conduct Charter

The Daiichi Sankyo Group Corporate Conduct Charter lays out the ten articles representing the most important principles of action related to corporate quality. All Group companies both in and outside Japan must observe these principles, which form the basis for the Group's CSR.

DAIICHI SANKYO Group Corporate Conduct Charter

The DAIICHI SANKYO Group fulfills its mission "To contribute to the enrichment of quality of life around the world through the creation of innovative pharmaceuticals, and through the provision of pharmaceuticals addressing diverse medical needs." We comply with laws, regulations and rules regarding global corporate activities, and act with the highest ethical standards and a good social conscience based on the following 10 principles of this Charter.

In order to actively respond to an ever-changing society, we address social issues and business in an integrated manner. It will enhance our corporate value, fulfill our social responsibilities and contribute to the realization of a sustainable society.

Article 1 Contribution to Healthcare

We diligently address medical needs by providing beneficial, safe, and reliable pharmaceuticals and services.

Article 2 Fair business practices

We respect international norms, diverse cultures and customs, conduct business in a fair manner through free and fair competition, and conduct responsible procurement by complying with laws and regulations in each country and region in which we do business. We maintain productive, positive and professional relationships with our stakeholders, which include medical professionals and governments.

Article 3 Fair disclosure of information and constructive dialogue with stakeholders

We actively, effectively and fairly disclose corporate information to the public and engage in an open and constructive dialogue with a wide range of stakeholders.

Article 4 Respect for human rights

We conduct business that respects the human rights of all persons.

Article 5 Enhancement of workplace environment and human resource development

We respect the diversity of our employees, and seek to include a diversity of thought in our daily work. We are committed to ensuring a healthy and safe working environment and do not tolerate harassment and discrimination. We provide employees the opportunity to develop their skills and abilities for the mutual growth of the individual employee and the corporation.

Article 6 Information management

We take necessary measures to manage and protect personal information, business partner information as well as other confidential information of Daiichi Sankyo and others.

Article 7 Engagement in environmental issues

Environmental challenges are universally critical to all of mankind. We responsibly manage the environmental impact of our operations and include our efforts for a better environment in our corporate activities and our very survival.

Article 8 Involvement in community and contribution to its development

We are actively involved in community activities and contribute to its development as a good corporate citizen.

Article 9 Thorough crisis and emergency management

We adhere to crisis and emergency management in the face of actions by antisocial forces, terrorism, cyber-attacks, natural disasters, pandemics and other significant issues that may threaten the order or safety of civil society and the corporate activity.

Article 10 Role of Executives and implementation of this Charter

Executives of the DAIICHI SANKYO Group actively build and maintain effective governance systems to implement this Charter, ensure it is understood by all Group companies, and encourage behavior based on the principles of this Charter to the business partners of Daiichi Sankyo Group. If the Charter is violated, executives of DAIICHI SANKYO Group Companies take responsibility to respond by determining the cause of infringement, taking corrective action as necessary and making efforts to prevent similar violations in the future.

Revised date: April 1st, 2019

Date of enforcement: September 28th, 2005

Revised date:April 1st, 2007

       April 1st, 2007

       April 1st, 2010

       October 1st, 2011

       April 1st, 2012

       June 1st, 2018

       April 1st, 2019

CSR Department

games hay nhất sitemap OneBet fun88 slot 1xbet live sbobet555 line sbobet555line scr888online gclub slot
www.jiudianzhaopin.com/bbbfg/0662.html| www.agenvimaxpills.com| www.jiudianzhaopin.com/bbbbf/vt99d/| www.itjie.com/bbsf/vpt9.html| www.w88vietna.com| www.thedancecloset.net| www.wqshingtonpost.com| www.congwestonucc.net| www.jquery-quickzoom.com| www.academicstudio.net| www.elsyaminstitute.com| www.jiudianzhaopin.com/bbbcs/tjxg/| www.jiudianzhaopin.com/vipaaosu.html| www.jiudianzhaopin.com/bbbqw/hlt.html| www.jiudianzhaopin.com/viptv9nt.html| www.jiudianzhaopin.com/viperw/335.html| www.bluewhaleonline.com| www.jiudianzhaopin.com/bbbcs/piwa/| www.monclerssale.com| www.360w88.com| www.w88wth.org| www.arkansasventures.net| www.oaswj.com| www.anti-ickypoo.com| www.jiudianzhaopin.com/vipbf/vt99d| www.daingerfieLdtx.net| www.w88wbet.com| www.yeshanlan.com| www.andrewheimann.com| www.jiudianzhaopin.com/bbbbf/11r7n/| www.gsmfastunlocker.net| www.jiudianzhaopin.com/bbbrx1dj.html| www.simonkirkeofficial.com| www.chenjing6.com| www.jiudianzhaopin.com/viperw/393.html| www.greatw88.com| www.jiudianzhaopin.com/vipzd3pl.html| www.jiudianzhaopin.com/bbbfg/0662.html| www.knowledgetail.com| www.eternelskincream.com| www.jiudianzhaopin.com/bbbfg/6080.html| www.jiudianzhaopin.com/bbbqw/575.html|